According to an article at Multiple Sclerosis News Today, at least one doctor at U.K. Healthcare’s Kentucky Neuroscience Institute wants more diversity in clinical trials. It’s not just about social equality – Dr. Jay Avasarala, a specialist in multiple sclerosis and neuroimmunology, knows that non-diverse clinical studies are having a real health impact on minorities. He has seen through his practice that Multiple sclerosis presents and progresses in completely different ways in black people and white people and this is where Dr. Avasarala’s concerns arise. Find out more.